Dr. Thienel has extensive medical, product development, and general management experience in early stage research through product commercialization. Prior to joining RRD International, LLC, Dr. Thienel was Vice President of Asset Strategy at Takeda. During his tenure at Takeda he oversaw multiple franchises including CNS, immunology, respiratory, and inflammation. Previously, he held clinical development positions in immunology at Bristol-Myers Squibb and drug-device combination products at Johnson and Johnson. Dr. Thienel has broad experience in all four phases of clinical development including the filing of multiple NDAs and BLAs. Therapeutic areas of focus have included autoimmune and inflammatory diseases, GvHD, and a broad range of neurological diseases. Dr. Thienel received his MD and PhD degrees from Justus-Liebig University in Giessen, Germany and completed his residency in internal medicine at Ludwigsburg Hospital / Heidelberg University. After moving to the US in 1996, he continued his fellowship in rheumatology at Columbia University in New York. In 2015 Dr. Thienel completed his executive training in sales and marketing at the Kellogg Institute, Northwestern University.